Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antituberculous agents.

R E Van Scoy1, C J Wilkowske

  • 1Division of Infectious Diseases and Internal Medicine, Mayo Clinic, Rochester, MN 55905.

Mayo Clinic Proceedings
|February 1, 1992
PubMed
Summary
This summary is machine-generated.

Antituberculous agents effectively treat tuberculosis, including extrapulmonary forms. Patient compliance and drug resistance are key challenges to successful tuberculosis treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ABO Blood Groups of Siblings of Duodenal Ulcer Patients.

British medical journal·2010
Same author

ABO Blood Groups of Siblings of Gastric Ulcer and Gastric Carcinoma Patients.

British medical journal·2010
Same author

Antimycobacterial therapy.

Mayo Clinic proceedings·2000
Same author

Long-term follow-up of multifocal osteoarticular sporotrichosis treated with itraconazole.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1996
Same author

Disseminated cutaneous Mycobacterium avium-intracellulare resembling sarcoidosis.

Journal of the American Academy of Dermatology·1995
Same author

Implementing an EMR: paper's last hurrah.

Proceedings. Symposium on Computer Applications in Medical Care·1995
Same journal

37-Year-Old Woman With Jaundice.

Mayo Clinic proceedings·2026
Same journal

34-Year-Old Woman With An Unidentified Overdose.

Mayo Clinic proceedings·2026
Same journal

Use of Bronchoscopic Cryobiopsy in Evaluating Interstitial Lung Disease: Radiologic Predictors of Diagnostic Yield and Safety.

Mayo Clinic proceedings·2026
Same journal

Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.

Mayo Clinic proceedings·2026
Same journal

RAAS Inhibition in the ICU: Stop, Continue, or Restart?

Mayo Clinic proceedings·2026
Same journal

Chronic Kidney Disease-In the Limelight, July 2026.

Mayo Clinic proceedings·2026
See all related articles

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Antituberculous agents have significantly improved tuberculosis outcomes, reducing the need for surgery.
  • Standard 6- and 9-month treatment regimens are generally successful for both pulmonary and extrapulmonary tuberculosis.
  • Effective management of tuberculosis relies on appropriate drug selection and administration.

Framework:

  • Treatment failure in tuberculosis is primarily linked to patient non-compliance with medication.
  • Antimicrobial resistance of tubercle bacilli is a critical factor contributing to treatment failure.
  • Physician expertise is essential for reassessing treatment when therapeutic failure is suspected.

Implementation:

  • Consistent patient adherence to prescribed antituberculous medication is crucial for treatment success.

Related Experiment Videos

  • Monitoring for and addressing drug resistance is vital in managing tuberculosis.
  • Extrapulmonary tuberculosis requires the same drug regimens as pulmonary tuberculosis.

    • Implications:

    • Prophylactic use of isoniazid for 6 to 12 months demonstrates effectiveness in preventing tuberculosis.
    • Understanding and mitigating treatment failure factors can optimize tuberculosis control strategies.
    • Further research into novel antitubercular therapies and resistance mechanisms is warranted.